Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) Short Interest Up 27.1% in October

Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) was the target of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 123,200 shares, an increase of 27.1% from the October 15th total of 96,900 shares. Approximately 0.7% of the shares of the company are short sold. Based on an average daily volume of 120,900 shares, the short-interest ratio is currently 1.0 days.

Inspira Technologies Oxy B.H.N. Stock Down 5.6 %

NASDAQ IINN traded down $0.07 during trading hours on Friday, hitting $1.18. The company had a trading volume of 116,554 shares, compared to its average volume of 442,285. Inspira Technologies Oxy B.H.N. has a fifty-two week low of $0.76 and a fifty-two week high of $2.49. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.23 and a quick ratio of 2.13. The business has a fifty day simple moving average of $1.31 and a 200-day simple moving average of $1.46.

Institutional Trading of Inspira Technologies Oxy B.H.N.

An institutional investor recently bought a new position in Inspira Technologies Oxy B.H.N. stock. Renaissance Technologies LLC purchased a new position in Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 24,497 shares of the company’s stock, valued at approximately $34,000. Renaissance Technologies LLC owned approximately 0.19% of Inspira Technologies Oxy B.H.N. at the end of the most recent quarter. 12.72% of the stock is currently owned by institutional investors.

Inspira Technologies Oxy B.H.N. Company Profile

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.